Breast Cancer Trial, Recruiting (NCT07206394)

Breast Cancer Trial, Recruiting NCT07206394 Sponsor: University College London Hospitals Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07206394 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years of age
People who have had breast surgery aimed at curing early-stage breast cancer
People who finished radiotherapy at least 6 months ago
People who are currently in remission with no signs of the cancer returning locally
People who rate their pain as 3 or more out of 10 on a pain scale, either for pain intensity or the burden pain places on daily life
People who speak English and are able to communicate reasonably well
People who are able to give informed consent to participate
People who are willing to attend regular treatment appointments at RLHIM

Who may not be able to join:

People who have a history of wound complications following breast surgery
People who have had breast surgery for reasons unrelated to breast cancer treatment
People who have previously received ScarWork therapy
People who have been diagnosed with lymphoedema (a condition involving swelling caused by a problem with the lymphatic system)
People with serious other health conditions or significant cognitive difficulties
People who are currently receiving physiotherapy specifically for pain related to their breast surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07206394

Sponsor: University College London Hospitals

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT07206394

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years of age
People who have had breast surgery aimed at curing early-stage breast cancer
People who finished radiotherapy at least 6 months ago
People who are currently in remission with no signs of the cancer returning locally
People who rate their pain as 3 or more out of 10 on a pain scale, either for pain intensity or the burden pain places on daily life
People who speak English and are able to communicate reasonably well
People who are able to give informed consent to participate
People who are willing to attend regular treatment appointments at RLHIM

Who may not be able to join:

People who have a history of wound complications following breast surgery
People who have had breast surgery for reasons unrelated to breast cancer treatment
People who have previously received ScarWork therapy
People who have been diagnosed with lymphoedema (a condition involving swelling caused by a problem with the lymphatic system)
People with serious other health conditions or significant cognitive difficulties
People who are currently receiving physiotherapy specifically for pain related to their breast surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University College London Hospitals

Registry

ClinicalTrials.gov

Start date

20 June 2025

Est. completion

31 March 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

BREAST-Q Breast Conserving Therapy Module V2.0

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov